Multicultural Marketing

Reach Your Target Audience and Maximize Your Brand’s Impact.

Learn More
mcm1

Multicultural Marketing Consulting for Life Sciences

Your Brand, Your Product, Your Messaging in Their Language

Whether you’re a corporation looking to adapt and target your branding, marketing, and advertising for new markets, or an agency working toward these goals on a client’s behalf, TransPerfect Life Sciences' multicultural marketing solutions help ensure maximum impact for your efforts.

Life Sciences Multicultural Consulting

Successful globalization requires more than just translation—it requires an in-depth understanding of the local culture and regulations. Regardless of the market you’re expanding into, if you’re a healthcare marketing agency, a patient recruitment agency, or life sciences organization, our specialized team of multilingual brand managers and global consultants will keep your brand and product commercialization on track.

Content & Campaign Adaption

Building an effective campaign means hours of work and detailed planning. When you’re expanding globally, adapting every single aspect of your messaging can be a monumental challenge. Ensure that your campaign and content stay true to your core messaging while meeting your launch expectations with expert insights into your target audience and cultural nuances—all while adhering to local market regulations.

Specialized Brand, Marketing, and Advertising Global Consulting for the Life Sciences Industry

Whether you’re entering a new market for the first time or finding ways to improve your global expansion, we have the experience and expertise to help you effectively adapt your product’s messaging to capture the local nuances of any market.

Maximize Your Brand’s Impact

Get a free consultation.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

The 5-Step AI Readiness Checklist for Medical Device Manufacturers

Only one in four manufacturers using process AI say it's meeting expectations. The gap between those results and the rest comes down to preparation. This checklist is built from patterns shared by manufacturers that are seeing results, along with the gaps most commonly found among those that aren't. ...

The 5-Step AI Readiness Checklist for Medical Device Manufacturers
Webinar

XTalks | How MI, PV & Regulatory Collaborate on Signals, Labeling, Crisis Response and AI

Medical Information (MI), Pharmacovigilance (PV) and Regulatory Affairs (RA) each play distinct but deeply interconnected roles in ensuring that therapeutics are safe, accurately labeled and compliantly communicated to healthcare professionals and patients. Yet in practice, the ...
Event

C3 Summit 2026 - San Francisco

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...
Webinar

LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts. ...
Blog

Regulatory Considerations for Paper COA Translations | What You Need to Know

Collecting data for a global clinical trial on paper COAs or managing a mixed-mode study that combines both paper and electronic formats means satisfying multiple regulatory bodies before a single patient enrolls. None of these entities operate on the same timeline or...
Blog

When "How Does the Patient Feel?" Became a Regulatory Question

For decades, clinical trials were built around things you could measure with a machine: tumor shrinkage on a scan, laboratory values, and disease progression. These hard, objective endpoints were the backbone of drug approval. The patient's own account of how they felt,...
Webinar

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects ...